Dr. Alexander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5310 Ball Camp Pike
Knoxville, TN 37921Phone+1 865-523-4704
Summary
- Dr. Ryan Alexander is a preventive medicine physician in Knoxville, TN and is affiliated with University of Tennessee Medical Center. He received his medical degree from Lincoln Memorial University Debusk College of Osteopathic Medicine and has been in practice 3 years. He specializes in public health & general preventive medicine and addiction medicine and is experienced in addiction medicine, opioid-related disorders, opioid overdose, population health / management, and alcohol use disorder. He has 3 publications and over 50 citings.
Education & Training
- Yale-New Haven Medical Center (Primary Care)Fellowship, Addiction Medicine, 2021 - 2022
- Griffin HospitalResidency, Public Health and General Preventive Medicine, 2019 - 2021
- Yale School of Public HealthMPH, 2019 - 2020
- University of Tennessee Medical Center at KnoxvilleInternship, Internal Medicine, 2017 - 2018
- Lincoln Memorial University DeBusk College of Osteopathic MedicineClass of 2017
Certifications & Licensure
- TN State License 2018 - 2025
- CT State License 2019 - 2022
- American Board of Preventive Medicine Public Health & General Preventive Medicine
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 48 citationsXylazine and Overdoses: Trends, Concerns, and Recommendations.Ryan S Alexander, Bethany R Canver, Kimberly L Sue, Kenneth L Morford
American Journal of Public Health. 2022-08-01 - 10 citationsThe Spectrum of Alcohol Use: Epidemiology, Diagnosis, and TreatmentShawn M Cohen, Ryan S Alexander, Stephen R. Holt
The Medical Clinics of North America. 2022-01-01 - Sociodemographic characteristics associated with hepatitis C among patients admitted for medically managed opioid withdrawal in east Tennessee.Ryan Alexander, Olayinka Agboola, Victoria C Costales
Journal of Addictive Diseases. 2021-06-13
Press Mentions
- Aegis Sciences Corporation Collaborates with the McNabb Center to Evaluate the Impact of Xylazine Exposure on Opioid WithdrawalDecember 17th, 2024
- Medicaid Limits Access to Life-Saving Doses of Addiction CareOctober 24th, 2024
- Fentanyl Is Only the Tip of the Iceberg of Drug Addiction | OpinionAugust 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: